PSI Paraguay was established in 1996 to serve low-income populations throughout Paraguay. In 2003, it transitioned from a donor-funded social marketing program into a financially independent, profitable social enterprise, using funds from product sales to address new gaps in the market. PSI Paraguay continuously looks for ways to support a socially conscious marketplace, improve the Paraguayan community’s significant health needs and serve as a leader in the contraceptive market.
Km 17,5 Yataity
Fracción H c/ Ruta José Félix
Estigarribia Ruta 2
Phone: + 595-21-600-654
Fax: + 595-228-633-633
Why Social Enterprise?
PSI Paraguay generates positive sales margins through its branded products and services, which it uses to assess new gaps in the market and assess ways in which it can continue to improve the country’s significant health needs. The brands Segura, Segura Plus, Pronta, VitalDía and Pantera are leaders in their respective markets. PSI Paraguay capitalized on its success in 2003 to transition from a donor-funded social marketing program into a financially independent, profitable social enterprise.
PSI Paraguay's Health Areas
Historically, PSI Paraguay has always taken an enterprise-style approach to global health challenges, coupling donor funding with marketing, the use of branded products and consumer insights from the private sector. Now, PSI leverages this approach in markets that can support social enterprises to fulfill donor expectations for more sustainable approaches. PSI uses sound marketing and business discipline in its social enterprises to ensure the long-term viability of consumer-powered healthcare by balancing the pursuit of social impact and financial self-reliance.
PSI Paraguay’s impact for its consumers includes:
years of protection from unintended pregnancy for couples
years of healthy life
Discover what's happening at PSI
Ask Kelly: ETHICS DURING COVID-19- Returning to In-person Research
By: Kelly O’Keefe, Research Ethics Senior Technical Advisor, PSI; Jennifer Wheeler, Deputy Director for Research, PSI; and Kristen Little, Senior Technical Advisor, Strategic Research, PSI Since the
In Memoriam to Bill Gates, Sr.
By Karl Hofmann, President & CEO, PSI Let me add our voices to those who have paid tribute to Bill Gates, Sr. His remarkable contributions to the work of
Infected and Affected: The Indirect Consequences of COVID-19 in Central America
By Jennifer Wheeler, PSI Deputy Director, Research, Paola Letona, PSI Evidence Regional Director, LAC, and Sussy Lungo, Regional Executive Director, Asociación PASMO “When you are
Five Market Indicators that Signal the Hormonal IUS will take off
By Kendal Danna, PSI Technical Advisor, Reproductive Health In 2017, with USAID support, PSI began piloting the introduction of the hormonal Intrauterine System (IUS), also